DeepHealth Completes Acquisition of iCAD, Expanding AI-Powered Breast Cancer Solutions Worldwide
I'm PortAI, I can summarize articles.
RadNet, Inc. has completed its acquisition of iCAD, Inc. through DeepHealth, enhancing AI-powered breast cancer solutions. This integration aims to accelerate AI adoption and improve access to advanced screening technologies globally. With iCAD’s AI portfolio and presence in over 1,500 healthcare locations, the partnership targets scaling DeepHealth’s impact to over 10 million mammograms annually, enhancing cancer detection and workflow efficiency.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments